Clinical trials are the best instrument to advance treatment for blood cancers, but numerous challenges exist around trial identification, enrollment, and participation. We’ll hear perspectives from a community provider and patient advocacy organization on immediate--and forward-thinking--solutions to help this population better access clinical trials, including a tool from the Leukemia and Lymphoma Society to help patients identify cancer clinical trials that may be a fit.

Guests: 

Ethan Binder, MD

Hematologist and OncologistPresbyterian Rust Medical Center

Rio Rancho, NM

Leah Szumita, MS, RN

Director, Clinical Trial Support CenterLeukemia & Lymphoma Society

Rye Brook, NY

Resources: 

• ACCC Community Oncology Research Institute 
• ACORI Call to Action Summit: Activating Equity in Community Oncology Research
• ASCO-ACCC Joint Research Statement
• Clinical Trial Support Center (CTSC)
• Leukemia & Lymphoma Society
• Research & Clinical Trial Resources at ACCC
• Ep 60: Advancing Clinical Trial Equity

This podcast is the first in a series from the ACCC Community Oncology Research Institute (ACORI).